Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017
Journal of Obstetrics and Gynaecology Research · 2025-11 · 51 (11)
DOI: 10.1111/jog.70124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 29.10.2025. Verfasst von Hiroaki Kajiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Registries, Medical Oncology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Aim
To provide information including the trend of gynecological malignancies in Japan, we hereby present the Annual Patient Report for 2022 and the Annual Treatment Report for 2017, on the outcomes of patients who started treatment in 2017.
Methods
The Japan Society of Obstetrics and Gynecology maintains an annual tumor registry, where information on gynecological malignancies from various participating institutions is gathered. The data of patients whose treatment with gynecologic malignancies was initiated in 2022 were analyzed retrospectively. Survival of the patients who started treatment with cervical, endometrial, and ovarian cancer in 2017 was analyzed by using the Kaplan–Meier, log–rank, and Wilcoxson tests.
Results
Treatment was initiated in 2022 for 8039 patients with cervical cancer, 14 518 with endometrial cancer, 8524 with ovarian, tubal, and peritoneal cancer, 2360 with ovarian borderline tumors, and with the others (270 vulvar cancer, 179 vaginal cancer, 539 uterine sarcoma, 48 uterine adenosarcoma, 158 trophoblastic diseases). This clinicopathological information was summarized as the Patient Annual Report. The 5‐year survival rates of the patients who initiated treatment in 2017 were as follows. For cervical cancer, the rates were 93.0%, 76.1%, 59.5%, and 28.3% for Stages I, II, III, and IV, respectively. For endometrial cancer, the rates were 94.9%, 88.8%, 72.7%, and 28.9% for Stages I, II, III, and IV, respectively. For ovarian cancer, the rates were 91.7%, 76.6%, 54.4%, and 45.2% for Stages I, II, III, and IV, respectively.
Conclusion
The annual tumor report is an important survey that provides knowledge on gynecological malignancy trends in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Information Science, Iwate Medical University, Yahaba, Japan.
- Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
ORCID-Profile: Satoshi Tamauchi, Toyomi Satoh
Zitieren
APA
Kajiyama, H., Tamauchi, S., Takahashi, F., Satoh, T., & Board Members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology (2025). Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017. Journal of Obstetrics and Gynaecology Research, 51(11). https://doi.org/10.1111/jog.70124
Vancouver
Kajiyama H, Tamauchi S, Takahashi F, Satoh T, Board Members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017. Journal of Obstetrics and Gynaecology Research. 2025;51(11). doi:10.1111/jog.70124
BibTeX
@article{Kajiyama2025,
author = {Kajiyama, Hiroaki and Tamauchi, Satoshi and Takahashi, Fumiaki and Satoh, Toyomi and Board Members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology, Board Members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology},
title = {Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
volume = {51},
number = {11},
doi = {10.1111/jog.70124}
}
EUVIMED